Just Filed Form 4s Show that Members of IMUC Board and Senior Mgmt Together Bought 580,000 Shrs.
Date of purchase: Sept. 20, 2013 (last bd mtg.); exercise price $2.70 ($1.566 million.) Obviously intended as a vote of confidence, but could also be taken as based on inside knowledge ofthe performance of ICT-107 as Yu is still directly involved in management and care of patients at Cedars Sinai, one of the principal trial sites.
Those Form 4s are actually reporting Stock Options (right to buy) at $2.70.....not actual purchases. If stock appreciates they can buy the options and have a gain....if stock declines, they don't buy and there is no loss.......far different than actually buying the stock outright.